论文部分内容阅读
快速性心律失常抢救有新药──美托洛尔(甲氧乙心安)注射液广州市医药工业研究所研制成功的选择性β受体阻滞剂──美托洛尔(甲氧乙心安)注射液,是国内首创的、为快速性心律失常抢救提供的一种可靠新药。经中国医学科学院阜外医院、中国人民解放军总医院(301医院...
Tachyarrhythmia rescue a new drug ─ ─ metoprolol (methoxyethe) injection Guangzhou Institute of Pharmaceutical Industry successfully developed selective β-blockers ─ metoprolol (methicillin) Injection, is the first in China to provide a reliable new drug for tachyarrhythmia rescue. After the Chinese Academy of Medical Sciences Fuwai Hospital, Chinese People’s Liberation Army General Hospital (301 Hospital ...